Isolation of Thioguanine Resistant Variants of K-BALB Cells Non-inducible for Type C Viruses by 5-Iododeoxyuridine

References

1. Aaronson S. A., Dunn C. Y. 1974a; Endogenous C-type viruses of Balb/c cells: frequencies of spontaneous and chemical induction. Journal of Virology 13:181–185
   [Google Scholar]
2. Aaronson S. A., Dunn C. Y. 1974b; High frequency C-type virus induction by inhibitors of protein synthesis. Science 183:422–424
   [Google Scholar]
3. Aaronson S. A., Stephenson J. R. 1973; Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proceedings of the National Academy of Sciences of the United States of America 70:2058
   [Google Scholar]
4. Aaronson S. A., Stephenson J. R. 1975; Differential cellular regulation of three distinct classes of type C RNA viruses endogenous to mouse cells. Cold Spring Harbor Symposium on Quantitative Biology 39:1129–1138
   [Google Scholar]
5. Aaronson S. A., Todaro G. J. 1968; Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science 162:1024–1026
   [Google Scholar]
6. Brockman R. W., Anderson E. P. 1963; Biochemistry of cancer (metabolic aspects). Annual Review of Biochemistry 32:463
   [Google Scholar]
7. Dunn C. Y., Aaronson S. A., Stephenson J. R. 1975; Interactions of chemical inducers and steroid enhancers of endogenous mouse type-C RNA viruses. Virology 66:578–588
   [Google Scholar]
8. Greenberger J. S., Aaronson S. A. 1975; Cycloheximide induction of xenotropic type C virus from synchronized mouse cells: metabolic requirements for virus activation. Journal of Virology 15:64–70
   [Google Scholar]
9. Hampar B., Derge J. G., Martos L. M., Tagamets M., Chang S.Y., Chakrabarty M. 1973; Identification of the Epstein-Barr virus by 5-iododeoxyuridine. Nature New Biology 244:214–217
   [Google Scholar]
10. Hatanaka M., Klein R., Toni R., Walker J., Gilden R. V. 1973; Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity. Journal of Experimental Medicine 138:356–363
    [Google Scholar]
11. Hitchings G. H., Elion G. B. 1967; Mechanisms of action of purine and pyrimidine analogs. In Cancer Chemotherapy p 26 Edited by Brodsky I., Kahn S. B., Moyer J. H. New York: Grune and Stratton;
    [Google Scholar]
12. Hladká M., Altaner C. 1974; Suppression of the avian sarcoma virus genone in hamster-transformed cells made resistant to 8-azaguanine. Journal of the National Cancer Institute 53:1221–1227
    [Google Scholar]
13. Hladká M., Altaner C. 1976; Suppression of the avian sarcoma virus genome in 8-azaguanine-resistant, transformed, hamster cells. Journal of the National Cancer Institute 57:283–287
    [Google Scholar]
14. Kim J. H., Gelbard A. S., Perez A. G., Eidinoff M. L. 1967; Effect of 5-bromodeoxyuridine on nucleic acid and protein synthesis and viability in HeLa cells. Biochimica et Biophysica Acta 134:388–395
    [Google Scholar]
15. Lieber M. M., Todaro G. J. 1973; Spontaneous and induced production of endogenous type-C RNA virus from a clonal line of spontaneous transformed BALB/3T3. International Journal of Cancer n:616–617
    [Google Scholar]
16. Long C., Chan T., Levytska V., Kusano T., Green H. 1973; Absence of demonstrable linkage of human genes for enzymes of the purine and pyrimidine salvage pathways in human-mouse somatic cell hybrids. Biochemical Genetics 9:283–297
    [Google Scholar]
17. Miller O. J., Cook P. R., Khan P. M., Shin S., Siniscalco M. 1971; Mitotic separation of two human x-linked genes in non-mouse somatic cell hybrids. Proceedings of the National Academy of Sciences of the United States of America 68:116–120
    [Google Scholar]
18. Nelson J. A., Carpenter J. W., Rose L. M., Adamson D. J. 1975; Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Research 35:2872–2878
    [Google Scholar]
19. Rowe W. P. 1973; Genetic factors in the natural history of murine leukemia virus infection: G. H. A. Clowes Memorial Lecture. Cancer Research 33:3061–3068
    [Google Scholar]
20. Schubert D., Jacob F. 1970; 5-bromodeoxyuridine-induced differentiation of a neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America 67:247–254
    [Google Scholar]
21. Schwartz S. A., Panem S., Kirsten W. H. 1975; Distribution and virogenic effects of 5-bromodeoxyuridine in synchronized rat embryo cells. Proceedings of the National Academy of Sciences of the United States of America 72:1829–1833
    [Google Scholar]
22. Silagi S., Bruce S. A. 1970; Suppression of malignancy and differentiation in melanotic melanoma cells. Proceedings of the National Academy of Sciences of the United States 66:72–78
    [Google Scholar]
23. Stellwagen R. H., Tomkins G. M. 1971; Differential effect of 5-bromodeoxyuridine on the concentrations of specific enzymes in hepatoma cells in culture. Proceedings of the National Academy of Sciences of the United States of America 68:1147–1150
    [Google Scholar]
24. Stephenson J. R., Crow J. D., Aaronson S. A. 1974; Differential activation of biologically distinguishable endogenous mouse type C RNA viruses: interaction with host cell regulatory factors. Virology 61:411–419
    [Google Scholar]
25. Teich N., Lowy D. R., Hartley J. W., Rowe W. P. 1973; Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine. Virology 51:163–173
    [Google Scholar]
26. Todaro G. J. 1972; ‘Spontaneous’ release of type C viruses from clonal lines of ‘spontaneously’ transformed Balb/3T3 cells. Nature New Biology 240:157–160
    [Google Scholar]
27. Wataya Y., Santi D. V. 1975; Thymidylate synthetase catalyzed dehalogenation of 5-bromo- and 5-iodo-2-deoxyuridylate. Biophysical and Biochemical Research Communications 67:818–823
    [Google Scholar]
28. Yoshikura H. 1975; Clonal variation of the mouse cells in the endogenous C-type virus induction by 5-iodo-2′-deoxyuridinc. Journal of General Virology 28:179–184
    [Google Scholar]